Prana Biotechnology Limited (ADR) (NASDAQ:PRAN)

CAPS Rating: 2 out of 5

The Company develops therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimer's disease.

Recs

0
Player Avatar pchop123 (80.37) Submitted: 12/4/2012 4:54:27 PM : Underperform Start Price: $2.30 PRAN Score: +4.92

Pump & Dumper ??

Featured Broker Partners


Advertisement